Background: Total homocysteine (tHcy) is associated with pregnancy complications and adverse pregnancy outcomes. The associations of plasma total cysteine (tCys) with such outcomes have not been investigated in large populations.
Objective: We investigated the association between plasma tCys and pregnancy complications, congenital malformations, and other adverse pregnancy outcomes.
Design: The plasma tCys concentrations of 5883 women aged 40-42 y that were measured in 1992-1993 during a cardiovascular health screening were compared with the outcomes and complications of 14492 pregnancies in the same women that were registered in the Medical Birth Registry of Norway from 1967 to 1996.
Results: After adjustment for parity, mother's age, tHcy, total cholesterol, body mass index, smoking, and coffee drinking, high plasma tCys concentrations (above the 95th percentile) were associated with significantly higher risks of preeclampsia [n = 342; odds ratio (OR): 1.6; 95% CI: 1.1, 2.4; P = 0.03], premature delivery (n = 774; OR: 1.8; 95% CI: 1.3, 2.5; P = 0.001), and very low birth weight (n = 175; OR: 2.0; 95% CI: 1.1, 3.9; P = 0.03) than were lower plasma tCys concentrations. tCys was not associated with the risk of placental abruption. High tCys concentrations showed a weak association with congenital malformations and stillbirths with birth weight <1500 g. The associations were independent of the tHcy concentrations.
Conclusion: High tCys concentrations were associated with risks of preeclampsia, premature delivery, and low birth weight.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/ajcn/77.2.467 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acute effects of oral mesna administration on the full amino acid profile and 3-methylhistidine: secondary results from the CYLOB dose-finding study.
Amino Acids
June 2024
Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
Plasma total cysteine (tCys) is strongly associated with fat mass in humans. Mesna lowers plasma tCys in a dose-dependent manner, but it is not known whether it interferes with metabolism of other amino acids or protein. In this Phase-1 study, we show that a single dose of mesna administered at 400, 800, 1200 or 1600 mg to 6-7 individuals per dose only slightly affects amino acid profiles, with increases in plasma valine across dose levels.
View Article and Find Full Text PDFSulphur Amino Acids: How Important is it to Set Reference Ranges for Each Population?
Endocr Metab Immune Disord Drug Targets
January 2024
Laboratory of Metabolism and Genetics, Department of Pharmaceutical Sciences and Medicines, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
Introduction: Metabolism of sulfur amino acids requires an optimal interplay between nutritional demand, enzymes, transporters, and adequate dietary intake of B vitamins. Insufficient intake and excess are detrimental, and concentrations depend on health status. However, plasma aminothiol concentrations, previously reported in healthy subjects using highly sensitive methods, vary considerably, and age- and gender differences were observed.
View Article and Find Full Text PDFCysteine-lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose-finding study.
Diabetes Obes Metab
November 2023
Department of Pharmacology, University of Oxford, Oxford, UK.
Aim: To investigate whether mesna-sodium-2-mercaptoethane sulfonate) can reduce diet-induced fat gain in mice, and to assess the safety of single ascending mesna doses in humans to find the dose associated with lowering of plasma tCys by at least 30%.
Methods: C3H/HeH mice were shifted to a high-fat diet ± mesna in drinking water; body composition was measured at weeks 0, 2 and 4. In an open, phase I, single ascending dose study, oral mesna (400, 800, 1200, 1600 mg) was administered to 17 men with overweight or obesity.
The Associations of Habitual Intake of Sulfur Amino Acids, Proteins and Diet Quality with Plasma Sulfur Amino Acid Concentrations: The Maastricht Study.
J Nutr
July 2023
Department of Internal Medicine, Maastricht University, Maastricht, the Netherlands; CARIM School for Cardiovascular Disease, Maastricht University, Maastricht, the Netherlands.
Article Synopsis
- Plasma sulfur amino acids (SAAs) like methionine and cysteine may contribute to obesity and cardiometabolic issues, but research on how diet affects their levels is limited.
- The study analyzed data from 1,145 participants to explore how dietary intake of SAAs and protein correlates with plasma SAA concentrations, utilizing food frequency questionnaires and various diet quality scores.
- Results indicated that higher intake of total SAAs and proteins was linked to increased plasma tCys and cystathionine, with specific intake patterns showing different effects on other SAAs and overall diet quality showing a connection to lower plasma tHcy levels.
The association of fasting plasma thiol fractions with body fat compartments, biomarker profile, and adipose tissue gene expression.
Amino Acids
March 2023
Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Blindern, Postboks 1046, Oslo, Norway.
People with high plasma total cysteine (tCys) have higher fat mass and higher concentrations of the atherogenic apolipoprotein B (apoB). The disulfide form, cystine, enhanced human adipogenesis and correlated with total fat mass in a Middle-Eastern cohort. In 35 European adults with overweight (88.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!